FocusType 2 Diabetes

Type 2 Diabetes: Genotype-Based Therapy

See allHide authors and affiliations

Science Translational Medicine  08 Oct 2014:
Vol. 6, Issue 257, pp. 257fs39
DOI: 10.1126/scitranslmed.3010687

You are currently viewing the abstract.

View Full Text


Targeting a genetic variant with an antagonist may restore insulin secretion in a subgroup of type 2 diabetes patients (Tang et al., this issue).

View Full Text